BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21658817)

  • 1. [Prevalence of micrometastases and isolated tumor cells in the sentinel node at early stage breast cancer].
    Cordero García JM; Palomar Muñoz A; Delgado Portela M; García Vicente AM; Pilkington Woll JP; Poblete García VM; Bellón Guardia ME; Pardo García R; Rabadán Ruiz L; Soriano Castrejón A
    Rev Esp Med Nucl Imagen Mol; 2012; 31(2):78-82. PubMed ID: 21658817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of sentinel lymph node micrometastases in patients with invasive breast carcinoma.
    Cipolla C; Graceffa G; La Mendola R; Fricano S; Fricano M; Vieni S
    Ann Ital Chir; 2015; 86():497-502. PubMed ID: 26898168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Axillary recurrences after sentinel lymph node biopsy in initial breast cancer].
    Sampol C; Giménez M; Torrecabota J; Serra C; Canet R; Daumal J; Peña C; Gonzalez L; Hernandez E; Graner A; Pozo A; Vega F
    Rev Esp Med Nucl; 2010; 29(5):241-5. PubMed ID: 20466461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Incidence of axillary recurrence after a negative sentinel lymph node result in early stages of breast cancer: a 5-year follow-up].
    Ruano Pérez R; Ramos Boyero M; García-Talavera Fernández JR; Ramos Grande T; González-Orús JM; Gómez-Caminero López F; García Macias MC; Martín de Arriba A
    Rev Esp Med Nucl Imagen Mol; 2012; 31(4):173-7. PubMed ID: 23067685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
    Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE
    Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Micrometastasis in the sentinel node and axillary lymph node macro-metastasis in breast cancer].
    Cordero García JM; Delgado Portela M; García Vicente AM; Pilkington Woll JP; Palomar Muñoz MA; Poblete García VM; Bellón Guardia ME; Pardo García R; Rabadán Ruiz L; Soriano Castrejón AM
    Rev Esp Med Nucl; 2010; 29(3):122-6. PubMed ID: 20398965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of completion axillary lymph node dissection in patients with breast cancer and isolated tumour cells or micrometastases in sentinel nodes.
    Houvenaeghel G; Boher JM; Reyal F; Cohen M; Garbay JR; Classe JM; Rouzier R; Giard S; Faure C; Charitansky H; Tunon de Lara C; Daraï E; Hudry D; Azuar P; Gimbergues P; Villet R; Sfumato P; Lambaudie E
    Eur J Cancer; 2016 Nov; 67():106-118. PubMed ID: 27640137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node biopsy in breast cancer New indications and our experience.
    Zanghì G; Rinzirillo NM; Caponnetto AM; Vecchio R; Catania V; Leanza V
    Ann Ital Chir; 2015; 86():508-12. PubMed ID: 26898363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
    Tvedskov TF
    Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sentinel node biopsy in T2 breast cancers larger than 3 cm and clinically negative axilla compared with the T1-T2 <3 cm standard indication].
    Ruano R; Ramos M; García-Talavera JR; García Macías MC; Martín de Arriba A; González-Orús JM; Iglesias M; Serrano E
    Rev Esp Med Nucl; 2008; 27(3):176-82. PubMed ID: 18570859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolution of the sentinel node procedure in the treatment of breast cancer.
    Tvedskov TF
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy.
    Langer I; Marti WR; Guller U; Moch H; Harder F; Oertli D; Zuber M
    Ann Surg; 2005 Jan; 241(1):152-8. PubMed ID: 15622003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Avoiding axillary treatment in sentinel lymph node micrometastases of breast cancer: a prospective analysis of axillary or distant recurrence.
    Pernas S; Gil M; Benítez A; Bajen MT; Climent F; Pla MJ; Benito E; Guma A; Gutierrez C; Pisa A; Urruticoechea A; Pérez J; Gil Gil M
    Ann Surg Oncol; 2010 Mar; 17(3):772-7. PubMed ID: 20183912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
    Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-validation of three predictive tools for non-sentinel node metastases in breast cancer patients with micrometastases or isolated tumor cells in the sentinel node.
    Tvedskov TF; Meretoja TJ; Jensen MB; Leidenius M; Kroman N
    Eur J Surg Oncol; 2014 Apr; 40(4):435-41. PubMed ID: 24534362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of isolated tumor cells and micrometastases of lymph nodes in early-stage breast cancer: a French sentinel node multicenter cohort study.
    Houvenaeghel G; Classe JM; Garbay JR; Giard S; Cohen M; Faure C; Hélène C; Belichard C; Uzan S; Hudry D; Azuar P; Villet R; Penault Llorca F; Tunon de Lara C; Goncalves A; Esterni B;
    Breast; 2014 Oct; 23(5):561-6. PubMed ID: 24874284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axillary treatment of patients with breast cancer and micrometastatic disease in the sentinel lymph node Our experience.
    Morlino A; La Torre G; Patitucci G; Cammarota A
    Ann Ital Chir; 2017; 88():360-364. PubMed ID: 29051403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy.
    Rebollo-Aguirre AC; Gallego-Peinado M; Menjón-Beltrán S; García-García J; Pastor-Pons E; Chamorro-Santos CE; Ramos-Font C; Salamanca-Ballesteros A; Llamas-Elvira JM; Olea-Serrano N
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):117-23. PubMed ID: 21676504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of sentinel lymph node biopsy prior to axillary lymph node dissection: the role of isolated tumor cells/micrometastases and multifocality/multicentricity-a retrospective study of 1214 breast cancer patients.
    Schröder L; Fricker R; Stein RG; Rink T; Fitz H; Blasius S; Wöckel A; Müller T
    Arch Gynecol Obstet; 2018 Jun; 297(6):1509-1515. PubMed ID: 29594495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.